Background Closed-loop artificial pancreas systems have been in development for several
years, including assessment in numerous varied outpatient clinical trials. We aimed to …

Objective To evaluate the efficacy and safety of artificial pancreas treatment in non-pregnant
outpatients with type 1 diabetes. Design Systematic review and meta-analysis of …

2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …

Background: The safety and effectiveness of the in-home use of a hybrid closed-loop (HCL)
system that automatically increases, decreases, and suspends insulin delivery in response …

The convergence of science and technology in our dynamic digital era has resulted in the
development of innovative digital health devices that allow easy and accurate …

Background The feasibility, safety, and efficacy of prolonged use of an artificial beta cell
(closed-loop insulin-delivery system) in the home setting have not been established …

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …

Closed-loop (artificial pancreas) systems for automated insulin delivery have been likened
to the holy grail of diabetes management. The first iterations of glucose-responsive insulin …

Background The safety and effectiveness of a continuous, day-and-night automated
glycaemic control system using insulin and glucagon has not been shown in a free-living …

Critical care, like many healthcare areas, is under a dual assault from significantly
increasing demographic and economic pressures. Intensive care unit (ICU) patients are …